401 related articles for article (PubMed ID: 35316296)
21. Myeloid differentiation of purified CD34+ cells after stimulation with recombinant human granulocyte-monocyte colony-stimulating factor (CSF), granulocyte-CSF, monocyte-CSF, and interleukin-3.
Egeland T; Steen R; Quarsten H; Gaudernack G; Yang YC; Thorsby E
Blood; 1991 Dec; 78(12):3192-9. PubMed ID: 1720697
[TBL] [Abstract][Full Text] [Related]
22. Tumour-associated myeloid cells expressing IL-10R2/IL-22R1 as a potential biomarker for diagnosis and recurrence of pancreatic ductal adenocarcinoma.
Lee HK; Kim SY; Chung SH; Choi B; Kim JE; Yoon D; Jang SI; Yeo A; Kang HG; Lee J; Choi YH; Park JS; Sung Y; Kim JK; Chang EJ; Lee DK
Br J Cancer; 2024 Jun; 130(12):1979-1989. PubMed ID: 38643339
[TBL] [Abstract][Full Text] [Related]
23. The development and maintenance of the mononuclear phagocyte system of the chick is controlled by signals from the macrophage colony-stimulating factor receptor.
Garceau V; Balic A; Garcia-Morales C; Sauter KA; McGrew MJ; Smith J; Vervelde L; Sherman A; Fuller TE; Oliphant T; Shelley JA; Tiwari R; Wilson TL; Chintoan-Uta C; Burt DW; Stevens MP; Sang HM; Hume DA
BMC Biol; 2015 Feb; 13():12. PubMed ID: 25857347
[TBL] [Abstract][Full Text] [Related]
24. Oncolytic virus-mediated reducing of myeloid-derived suppressor cells enhances the efficacy of PD-L1 blockade in gemcitabine-resistant pancreatic cancer.
Kajiwara Y; Tazawa H; Yamada M; Kanaya N; Fushimi T; Kikuchi S; Kuroda S; Ohara T; Noma K; Yoshida R; Umeda Y; Urata Y; Kagawa S; Fujiwara T
Cancer Immunol Immunother; 2023 May; 72(5):1285-1300. PubMed ID: 36436021
[TBL] [Abstract][Full Text] [Related]
25. Colony-stimulating factor-1 and colony-stimulating factor-1 receptor co-expression is associated with disease progression in gastric cancer.
Okugawa Y; Toiyama Y; Ichikawa T; Kawamura M; Yasuda H; Fujikawa H; Saigusa S; Ohi M; Araki T; Tanaka K; Inoue Y; Tanaka M; Miki C; Kusunoki M
Int J Oncol; 2018 Aug; 53(2):737-749. PubMed ID: 29767252
[TBL] [Abstract][Full Text] [Related]
26. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects.
Dai XM; Ryan GR; Hapel AJ; Dominguez MG; Russell RG; Kapp S; Sylvestre V; Stanley ER
Blood; 2002 Jan; 99(1):111-20. PubMed ID: 11756160
[TBL] [Abstract][Full Text] [Related]
27. Function of CSF1 and IL34 in Macrophage Homeostasis, Inflammation, and Cancer.
Lin W; Xu D; Austin CD; Caplazi P; Senger K; Sun Y; Jeet S; Young J; Delarosa D; Suto E; Huang Z; Zhang J; Yan D; Corzo C; Barck K; Rajan S; Looney C; Gandham V; Lesch J; Liang WC; Mai E; Ngu H; Ratti N; Chen Y; Misner D; Lin T; Danilenko D; Katavolos P; Doudemont E; Uppal H; Eastham J; Mak J; de Almeida PE; Bao K; Hadadianpour A; Keir M; Carano RAD; Diehl L; Xu M; Wu Y; Weimer RM; DeVoss J; Lee WP; Balazs M; Walsh K; Alatsis KR; Martin F; Zarrin AA
Front Immunol; 2019; 10():2019. PubMed ID: 31552020
[TBL] [Abstract][Full Text] [Related]
28. PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS/Notch/Nodal Signaling.
Sprouse ML; Welte T; Boral D; Liu HN; Yin W; Vishnoi M; Goswami-Sewell D; Li L; Pei G; Jia P; Glitza-Oliva IC; Marchetti D
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003475
[TBL] [Abstract][Full Text] [Related]
29. Effects of bone marrow fibroblasts on the proliferation and differentiation of myeloid leukemic cell lines.
Stolze B; Emmendörffer A; Corbacioglu S; König A; Welte K; Ebell W
Exp Hematol; 1995 Dec; 23(13):1378-87. PubMed ID: 7498367
[TBL] [Abstract][Full Text] [Related]
30. Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells.
Wei S; Nandi S; Chitu V; Yeung YG; Yu W; Huang M; Williams LT; Lin H; Stanley ER
J Leukoc Biol; 2010 Sep; 88(3):495-505. PubMed ID: 20504948
[TBL] [Abstract][Full Text] [Related]
31. Targeting the CSF1/CSF1R axis is a potential treatment strategy for malignant meningiomas.
Yeung J; Yaghoobi V; Miyagishima D; Vesely MD; Zhang T; Badri T; Nassar A; Han X; Sanmamed MF; Youngblood M; Peyre M; Kalamarides M; Rimm DL; Gunel M; Chen L
Neuro Oncol; 2021 Nov; 23(11):1922-1935. PubMed ID: 33914067
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-10 inhibits spontaneous colony-forming unit-granulocyte-macrophage growth from human peripheral blood mononuclear cells by suppression of endogenous granulocyte-macrophage colony-stimulating factor release.
Oehler L; Foedinger M; Koeller M; Kollars M; Reiter E; Bohle B; Skoupy S; Fritsch G; Lechner K; Geissler K
Blood; 1997 Feb; 89(4):1147-53. PubMed ID: 9028936
[TBL] [Abstract][Full Text] [Related]
33. Antitumor activity of a pexidartinib bioisostere inhibiting CSF1 production and CSF1R kinase activity in human hepatocellular carcinoma.
Awasthi BP; Guragain D; Chaudhary P; Jee JG; Kim JA; Jeong BS
Chem Biol Interact; 2023 Jan; 369():110255. PubMed ID: 36368339
[TBL] [Abstract][Full Text] [Related]
34. In vivo production of interleukin-5, granulocyte-macrophage colony-stimulating factor, macrophages colony-stimulating factor, and interleukin-6 during intravenous administration of high-dose interleukin-2 in cancer patients.
Schaafsma MR; Falkenburg JH; Landegent JE; Duinkerken N; Osanto S; Ralph P; Kaushansky K; Wagemaker G; Van Damme J; Willemze R
Blood; 1991 Oct; 78(8):1981-7. PubMed ID: 1912580
[TBL] [Abstract][Full Text] [Related]
35. Recombinant interleukin 3 induces interleukin 2 receptor expression on early myeloid cells in normal human bone marrow.
Gazzola MV; Collins NH; Tafuri A; Keever CA
Exp Hematol; 1992 Feb; 20(2):201-8. PubMed ID: 1371965
[TBL] [Abstract][Full Text] [Related]
36. Duffy antigen receptor for chemokines (DARC) expressing in cancer cells inhibits tumor progression by suppressing CXCR2 signaling in human pancreatic ductal adenocarcinoma.
Maeda S; Kuboki S; Nojima H; Shimizu H; Yoshitomi H; Furukawa K; Miyazaki M; Ohtsuka M
Cytokine; 2017 Jul; 95():12-21. PubMed ID: 28214673
[TBL] [Abstract][Full Text] [Related]
37. Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes.
Suzuki H; Katayama N; Ikuta Y; Mukai K; Fujieda A; Mitani H; Araki H; Miyashita H; Hoshino N; Nishikawa H; Nishii K; Minami N; Shiku H
Am J Hematol; 2004 Apr; 75(4):179-89. PubMed ID: 15054806
[TBL] [Abstract][Full Text] [Related]
38. High-grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF-1.
Steins A; van Mackelenbergh MG; van der Zalm AP; Klaassen R; Serrels B; Goris SG; Kocher HM; Waasdorp C; de Jong JH; Tekin C; Besselink MG; Busch OR; van de Vijver MJ; Verheij J; Dijk F; van Tienhoven G; Wilmink JW; Medema JP; van Laarhoven HW; Bijlsma MF
EMBO Rep; 2020 May; 21(5):e48780. PubMed ID: 32173982
[TBL] [Abstract][Full Text] [Related]
39. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines.
Budel LM; Delwel R; van Buitenen C; Hoogerbrugge H; Löwenberg B
Leukemia; 1993 Mar; 7(3):426-34. PubMed ID: 7680401
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor.
Menetrier-Caux C; Montmain G; Dieu MC; Bain C; Favrot MC; Caux C; Blay JY
Blood; 1998 Dec; 92(12):4778-91. PubMed ID: 9845545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
